期刊文献+

他汀类药物在冠心病中的治疗效果观察 被引量:8

Effect Observation of Statins in the Treatment of Coronary Heart Disease
暂未订购
导出
摘要 目的:研究他汀类药物在冠心病治疗过程中的疗效。方法:选取笔者所在医院70例确诊的冠心病患者,将他们随机分为观察组和常规组,各35例,常规组患者进行常规治疗,观察组患者在常规治疗基础上进行他汀类药物治疗。观察比较两组治疗前后各项指标。结果:两组治疗后各项指标均有明显降低,但观察组下降幅度更大。观察组治疗前后各项指标比较差异有统计学意义(P<0.05)。结论:他汀类药物可以有效治疗冠心病,是治疗冠心病的重要方法之一。 Objective:To study the treatment efficacy of statins in the treatment of coronary heart disease.Method:70 patients who were diagnosed with coronary heart disease in the hospital were selected,they were randomly divided into observation group and conventional group,each group had 35 cases,patients in the conventional group were given routine treatment,patients in the observation group were given statins therapy on the basis of routine treatment.The indicators before and after treatment were observed and compared in the two groups.Result:The indicators of two groups had significantly reduced after treatment,but the indicators of the observation group fell even more sharply.The indicators of the observation group before and after treatment were significant differences(P〈0.05). Conclusion:Statins can be effective in treating coronary heart disease,the treatment of coronary heart disease is one important way.
机构地区 四会市人民医院
出处 《中外医学研究》 2014年第5期10-11,共2页 CHINESE AND FOREIGN MEDICAL RESEARCH
关键词 他汀类药物 冠心病 治疗效果 Statins Coronary heart disease Curative effect
  • 相关文献

参考文献12

二级参考文献96

共引文献73

同被引文献52

  • 1赵水平,肖志杰,李全忠,聂赛,谭利民,蒋波,吴军.ATP结合盒转运子A1基因R219K变异对血脂的影响[J].中华医学杂志,2004,84(17):1421-1425. 被引量:11
  • 2栗德林,栗明,翟铁军.芪玄益心胶囊对糖尿病大鼠缺血心室肌细胞动作电位及瞬时外向钾电流的影响[J].天津中医药,2006,23(4):327-331. 被引量:6
  • 3汤玮,杨勇,刘惠亮.他汀类药物在慢性心力衰竭治疗中的研究进展[J].中华临床医师杂志(电子版),2012,6(20):6470-6472.
  • 4WANG Y. Correlation of ATP-binding transporter AI gene polymorphism with lipid metabolism and the risk of carotid plaque [D]. Zhejiang: Zhejiang University, 2012.
  • 5LI Y Y, ZHANG H, Q1N X Y, et al. ATP-binding cassette transporter A1 R219K polyrnorphism and coronary artery disease in Chinese population: a meta-analysis of 5388 participants [J]. Mol Biol Rep, 2012, 39(12): 11031-11039.
  • 6HIRONOBU A, ELIANA P, ERNST J S, et al. ABCA1 gene variation and heart disease risk reduction in the elderly during pravastatin treatment [J]. Atherosclerosis, 2014, 235(2014): 176-181.
  • 7ZWARTS K Y, CLEE S M, ZWINDERMAN A H, et al. ABCA1 regulatory variants influence coronary artery disease independent of effects on plasma lipid levels [J]. Clin Genet, 2002, 61(2): 115-125.
  • 8BILLARD A, LAVAL V, FILLINGER S, et al. The allele-specific probe and primer amplification assay, a new real-time PCR method for fine quantification of single-nueleotide polymorphisms in pooled DNA [J]. Appl Environ Microbiol, 2013, 78(4): 1063-1068.
  • 9YANG L, TANG K F, ZHOU K J, et al. Quantitative assessment of the effect of ABCA 1 R219K polymorphism on the risk of coronary heart disease [J]. Mol Biol Rep, 2012, 39(2): 1809-1813.
  • 10曹健,蒋跃绒.不同他汀类药物治疗冠心病的疗效对比[J].检验医学与临床,2014,1(3):1060-1061.

引证文献8

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部